- Home
- LYRA vs HYFM Comparison
LYRA vs HYFM Comparison
Compare LYRA & HYFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYRA
- HYFM
- Stock Information
- Founded
- LYRA 2005
- HYFM 1977
- Country
- LYRA United States
- HYFM United States
- Employees
- LYRA N/A
- HYFM N/A
- Industry
- LYRA Medical/Dental Instruments
- HYFM Industrial Machinery/Components
- Sector
- LYRA Health Care
- HYFM Industrials
- Exchange
- LYRA Nasdaq
- HYFM Nasdaq
- Market Cap
- LYRA 15.0M
- HYFM 16.0M
- IPO Year
- LYRA 2020
- HYFM 2020
- Fundamental
- Price
- LYRA $9.40
- HYFM $3.57
- Analyst Decision
- LYRA Buy
- HYFM Hold
- Analyst Count
- LYRA 2
- HYFM 2
- Target Price
- LYRA $16.00
- HYFM $7.00
- AVG Volume (30 Days)
- LYRA 1.9M
- HYFM 10.6K
- Earning Date
- LYRA 08-13-2025
- HYFM 08-07-2025
- Dividend Yield
- LYRA N/A
- HYFM N/A
- EPS Growth
- LYRA N/A
- HYFM N/A
- EPS
- LYRA N/A
- HYFM N/A
- Revenue
- LYRA $1,185,000.00
- HYFM $176,650,000.00
- Revenue This Year
- LYRA N/A
- HYFM $5.45
- Revenue Next Year
- LYRA $1,286.17
- HYFM $5.33
- P/E Ratio
- LYRA N/A
- HYFM N/A
- Revenue Growth
- LYRA N/A
- HYFM N/A
- 52 Week Low
- LYRA $3.81
- HYFM $1.50
- 52 Week High
- LYRA $37.50
- HYFM $8.55
- Technical
- Relative Strength Index (RSI)
- LYRA 45.31
- HYFM 50.79
- Support Level
- LYRA $10.15
- HYFM $3.50
- Resistance Level
- LYRA $14.88
- HYFM $3.83
- Average True Range (ATR)
- LYRA 2.03
- HYFM 0.36
- MACD
- LYRA -0.67
- HYFM -0.01
- Stochastic Oscillator
- LYRA 0.42
- HYFM 36.28
About LYRA Lyra Therapeutics Inc.
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.
About HYFM Hydrofarm Holdings Group Inc.
Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.